Obesity and Diabetes

Patients with type 2 diabetes are obese, and the global epidemic of obesity, its incidence and prevalence of type 2 diabetes over the past 20 years has given glance of diabetes in recent times. Excess weight is the main risk factor for type 2 diabetes, most of the obese individuals do not develop type 2 diabetes. Recent studies have identified relation between obesity and type 2 diabetes as it involves proinflammatory cytokines (tumor necrosis factor and interleukin-6), insulin resistance, deranged fatty acid metabolism, and cellular processes such as mitochondrial dysfunction and endoplasmic reticulum stress. These interactions are complex, and each of the are unclearly defined. Further genetic studies may elucidate additional  pathophysiological pathways for obesity and diabetes and identify promising new treatment targets. As physicians frequently prescribe glucose lowering medications associated with weight gain, as it results in  glycemic control and body weight and  current therapeutic options need more consideration. The issue is particularly concentrating on the evidence that even modest weight reduction whether through lifestyle or behavioral interventions, obesity medications, or bariatric surgery can improve glycemic control and reduce diabetes risk.

  • Type-2 Diabetes
  • Nutritional Therapy
  • Role of Hyperinsulinism
  • Obesity and Adipose Tissue Biology
  • Normal Insulin Sensitivity
  • Obesity Dependent Diabetes: Treatment

Related Conference of Obesity and Diabetes

June 10-11, 2024

24th Global Summit on Obesity

Dubai, UAE
June 27-28, 2024

20th Euro Obesity and Endocrinology Congress

London, UK
August 29-30, 2024

18th International Conference on Obesity Medicine

Helsinki, Finland
November 28-29, 2024

25th Annual Meet on Obesity and Diet

Bali, Indonesia

Obesity and Diabetes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in